(e,e,e,e)-squalene

(e,e,e,e)-squalene is a lipid of Fatty Acyls (FA) class. (e,e,e,e)-squalene is associated with abnormalities such as Hypercholesterolemia and Cataract. The involved functions are known as Process, metaplastic cell transformation, Protein Overexpression, Anabolism and Biosynthetic Pathways. (e,e,e,e)-squalene often locates in Membrane, Protoplasm, Plasma membrane, Tissue membrane and Back. The associated genes with (e,e,e,e)-squalene are Genome, IMPACT gene, GAPDH gene, GTF2I gene and Chromatin. The related lipids are Membrane Lipids, cycloartenol, Sterols, Fatty Acids and Nonesterified Fatty Acids.

Cross Reference

Introduction

To understand associated biological information of (e,e,e,e)-squalene, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with (e,e,e,e)-squalene?

(e,e,e,e)-squalene is suspected in Hypercholesterolemia, Cataract and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (e,e,e,e)-squalene

MeSH term MeSH ID Detail
Leukemia P388 D007941 43 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukemia, Hairy Cell D007943 5 associated lipids
Lipodystrophy D008060 4 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Nervous System Diseases D009422 37 associated lipids
Neuroblastoma D009447 66 associated lipids
Per page 10 20 50 100 | Total 84

PubChem Associated disorders and diseases

What pathways are associated with (e,e,e,e)-squalene

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with (e,e,e,e)-squalene?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with (e,e,e,e)-squalene?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with (e,e,e,e)-squalene

Download all related citations
Per page 10 20 50 100 | Total 1766
Authors Title Published Journal PubMed Link
Uusitupa MI et al. Lathosterol and other non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat bran. 1997 Eur J Clin Nutr pmid:9306087
Wendt KU et al. Structure and function of a squalene cyclase. 1997 Science pmid:9295270
Donald KA et al. Effects of overproduction of the catalytic domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase on squalene synthesis in Saccharomyces cerevisiae. 1997 Appl. Environ. Microbiol. pmid:9292983
Hamdan JS and Casali AK Effect of amphotericin B on the lipids of yeast cells of Sporothrix schenckii. 1996-1997 Mycopathologia pmid:9276941
Cenedella RJ Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols. 1997 Exp. Eye Res. pmid:9237866
Barnett SW et al. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. 1997 Vaccine pmid:9234536
Flint OP et al. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro. 1997 Toxicol. Appl. Pharmacol. pmid:9221828
Fliesler SJ et al. Squalene is localized to the plasma membrane in bovine retinal rod outer segments. 1997 Exp. Eye Res. pmid:9176062
Kuchta T et al. Inhibition of ergosterol biosynthesis is not accompanied by a change in fatty acid composition in Saccharomyces cerevisiae treated with the antifungal agent 6-amino-2-n-pentylthiobenzothiazole. 1997 FEMS Microbiol. Lett. pmid:9163904
Morand OH et al. Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin. 1997 J. Lipid Res. pmid:9162756
Wiss O and Wiss V On metabolic degradations of squalene, lanosterol and cholesterol in rat liver in vivo. Evidence for recycling of metabolites for the synthesis of isoprene compounds. 1977 Helv. Chim. Acta pmid:914630
Perzl M et al. Squalene-hopene cyclase from Bradyrhizobium japonicum: cloning, expression, sequence analysis and comparison to other triterpenoid cyclases. 1997 Microbiology (Reading, Engl.) pmid:9141686
Kawakami T et al. Evaluation of heterotopic bone formation induced by squalane and bone morphogenetic protein composite. 1997 Clin. Orthop. Relat. Res. pmid:9137198
Granoff DM et al. MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine. 1997 Infect. Immun. pmid:9125551
Gylling H et al. Delayed postprandial retinyl palmitate and squalene removal in a patient heterozygous for apolipoprotein A-IFIN mutation (Leu 159-->Arg) and low HDL cholesterol level without coronary artery disease. 1996 Atherosclerosis pmid:9125314
Rangel H et al. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes. 1996 Antimicrob. Agents Chemother. pmid:9124841
Eisele B et al. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivo. 1997 J. Lipid Res. pmid:9101437
Kushiro T et al. In vitro conversion of 2,3-oxidosqualene into dammarenediol by Panax ginseng microsomes. 1997 Biol. Pharm. Bull. pmid:9084891
O'Hagan DT et al. Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles. 1997 Mol Med Today pmid:9060004
Baum CL et al. Sterol carrier protein-2 overexpression enhances sterol cycling and inhibits cholesterol ester synthesis and high density lipoprotein cholesterol secretion. 1997 J. Biol. Chem. pmid:9045674
Downing DT et al. The time course of lipid formation in human sebaceous glands. 1977 J. Invest. Dermatol. pmid:903669
Beytía ED and Porter JW Biochemistry of polyisoprenoid biosynthesis. 1976 Annu. Rev. Biochem. pmid:9026
Nikkilä K et al. Serum squalene and noncholesterol sterols before and after delivery in normal and cholestatic pregnancy. 1996 J. Lipid Res. pmid:9017519
Stach D et al. Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase. 1997 J. Med. Chem. pmid:9003518
Krisans SK Cell compartmentalization of cholesterol biosynthesis. 1996 Ann. N. Y. Acad. Sci. pmid:8993542
Traquina P et al. MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates. 1996 J. Infect. Dis. pmid:8940205
Grimes DS et al. Sunlight, cholesterol and coronary heart disease. 1996 QJM pmid:8935479
Fujie T et al. Culture of cells derived from the human sebaceous gland under serum-free conditions without a biological feeder layer or specific matrices. 1996 Arch. Dermatol. Res. pmid:8931874
Kohashi O et al. Effect of oil composition on both adjuvant-induced arthritis and delayed hypersensitivity to purified protein derivative and peptidoglycans in various rat strains. 1977 Infect. Immun. pmid:892904
Dogliotti M et al. Nutritional influences of pellagra on sebum composition. 1977 Br. J. Dermatol. pmid:889695
Ferguson JB and Bloch K Purification and properties of a soluble protein activator of rat liver squalene epoxidase. 1977 J. Biol. Chem. pmid:885856
Bonté F et al. Simarouba amara extract increases human skin keratinocyte differentiation. 1996 J Ethnopharmacol pmid:8844461
Mark M et al. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells. 1996 J. Lipid Res. pmid:8820110
Gloor M and Kohler H A contribution to a new test method for dandruff-inhibiting and "keratolytic" action of drugs. 1977 Eur. J. Clin. Pharmacol. pmid:880976
Simon SA et al. The noneffect of a large linear hydrocarbon, squalene, on the phosphatidylcholine packing structure. 1977 Biophys. J. pmid:880329
Piretti MV et al. Simultaneous reversed-phase high-performance liquid chromatographic separation of non-polar isoprenoid lipids and their determination. 1995 J. Chromatogr. B, Biomed. Appl. pmid:8788146
Airaudi D et al. In vitro susceptibility of fungi to acyclic inhibitors of 2,3-oxidosqualene cyclases. 1996 Jan-Feb Mycoses pmid:8786759
Higgins DA et al. MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice. 1996 Vaccine pmid:8782343
Miquel K et al. Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. 1996 Biochem. Biophys. Res. Commun. pmid:8780704
Arthington-Skaggs BA et al. Positive and negative regulation of a sterol biosynthetic gene (ERG3) in the post-squalene portion of the yeast ergosterol pathway. 1996 FEBS Lett. pmid:8772195
Keefer MC et al. Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group. 1996 AIDS Res. Hum. Retroviruses pmid:8744579
Lakshmanan MR and Veech RL Measurement of rate of rat liver sterol synthesis in vivo using tritiated water. 1977 J. Biol. Chem. pmid:873910
Chan P et al. Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia. 1996 J Clin Pharmacol pmid:8739021
Gylling H et al. The metabolism of cholestanol in primary biliary cirrhosis. 1996 J. Hepatol. pmid:8738731
Fogelman AM et al. Cholesterol biosynthesis in human lymphocytes, monocytes, and granulocytes. 1977 Biochem. Biophys. Res. Commun. pmid:869944
Yamada Y et al. Oxidation of linear terpenes and squalene variants by Arthrobacter sp. 1977 Appl. Environ. Microbiol. pmid:869527
Fan SR et al. Squalene inhibits sodium arsenite-induced sister chromatid exchanges and micronuclei in Chinese hamster ovary-K1 cells. 1996 Mutat. Res. pmid:8692222
Barth MM et al. Structural and stereoelectronic requirements for the inhibition of mammalian 2,3-oxidosqualene cyclase by substituted isoquinoline derivatives. 1996 J. Med. Chem. pmid:8691425
Yoshino S Oral administration of type II collagen suppresses non-specifically induced chronic arthritis in rats. 1996 Biomed. Pharmacother. pmid:8672728
Ito T et al. Hepatic cholesterol metabolism in patients with cholesterol gallstones: enhanced intracellular transport of cholesterol. 1996 Gastroenterology pmid:8613070